Chun‐Wei Peng
About
In The Last Decade
Chun‐Wei Peng
62 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Molecular Biology 1.0k
- Oncology 660
- Cancer Research 525
- Biomedical Engineering 396
- Pulmonary and Respiratory Medicine 378
Countries citing papers authored by Chun‐Wei Peng
This map shows the geographic impact of Chun‐Wei Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chun‐Wei Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chun‐Wei Peng more than expected).
Fields of papers citing papers by Chun‐Wei Peng
This network shows the impact of papers produced by Chun‐Wei Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chun‐Wei Peng. The network helps show where Chun‐Wei Peng may publish in the future.
Co-authorship network of co-authors of Chun‐Wei Peng
This figure shows the co-authorship network connecting the top 25 collaborators of Chun‐Wei Peng. A scholar is included among the top collaborators of Chun‐Wei Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chun‐Wei Peng. Chun‐Wei Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 12 | |
| 3 | 18 | |
| 4 | 51 | |
| 5 | 20 | |
| 6 | 40 | |
| 7 | 49 | |
| 8 | 17 | |
| 9 | 27 | |
| 10 | Collagen as a double-edged sword in tumor progression breakdown → | 436 |
| 11 | 6 | |
| 12 | 36 | |
| 13 | 22 | |
| 14 | 27 | |
| 15 | High Ki-67 expression is a poor prognostic indicator of 5-year recurrence free survival in patients with invasive breast cancer. | 14 |
| 16 | 42 | |
| 17 | 33 | |
| 18 | 50 | |
| 19 | 77 | |
| 20 | 55 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.